ABBV vs CVS
By Alex · Tickerpine
AbbVie Inc. vs CVS Health Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | CVS |
|---|---|---|
| Price | $253.35 | $104.34 |
| Market cap | $447.62B | $133.13B |
| P/E ratio | 123.6 | 45.6 |
| ROE | — | 3.75% |
| Profit margin | 5.79% | 0.72% |
| Revenue growth | 12.40% | 6.10% |
| Dividend yield | 2.73% | 2.55% |
| Beta | 0.31 | 0.62 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs CVS in plain English
- ABBV is the bigger company — about 3.4× the market cap of CVS.
- CVS is cheaper on earnings (P/E 45.6 vs 123.6).
- ABBV is growing revenue faster (12% vs 6%).
- ABBV has the higher dividend yield (2.73% vs 2.55%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
CVS return calculator
See what $1,000 in CVS Health Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.